These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 30940565)

  • 1. Structure-activity relationship study of estrogen receptor down-regulators with a diphenylmethane skeleton.
    Nanjyo S; Ohgane K; Yoshioka H; Makishima M; Hashimoto Y; Noguchi-Yachide T
    Bioorg Med Chem; 2019 May; 27(10):1952-1961. PubMed ID: 30940565
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis and evaluation of tamoxifen derivatives with a long alkyl side chain as selective estrogen receptor down-regulators.
    Shoda T; Kato M; Harada R; Fujisato T; Okuhira K; Demizu Y; Inoue H; Naito M; Kurihara M
    Bioorg Med Chem; 2015 Jul; 23(13):3091-6. PubMed ID: 26003343
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structure-activity relationships of bisphenol A analogs at estrogen receptors (ERs): discovery of an ERα-selective antagonist.
    Maruyama K; Nakamura M; Tomoshige S; Sugita K; Makishima M; Hashimoto Y; Ishikawa M
    Bioorg Med Chem Lett; 2013 Jul; 23(14):4031-6. PubMed ID: 23768907
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A new class of 1,3,5-triazine-based selective estrogen receptor degraders (SERDs): Lead optimization, molecular docking and dynamic simulation.
    Lu X; Huang A; Xiao M; Sun L; Mao J; Luo G; Xiang H
    Bioorg Chem; 2020 Apr; 97():103666. PubMed ID: 32088420
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tamoxifen and Fulvestrant Hybrids Showed Potency as Selective Estrogen Receptor Down-Regulators.
    Shoda T; Kato M; Fujisato T; Demizu Y; Inoue H; Naito M; Kurihara M
    Med Chem; 2017; 13(3):206-213. PubMed ID: 27494098
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel class of 7-Oxabicyclo[2.2.1]heptene sulfonamides with long alkyl chains displaying improved estrogen receptor α degradation activity.
    Hu Z; Li Y; Xie B; Ning W; Xiao Y; Huang Y; Zhao C; Huang J; Dong C; Zhou HB
    Eur J Med Chem; 2019 Nov; 182():111605. PubMed ID: 31437778
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Quest for Orally Available Selective Estrogen Receptor Degraders (SERDs).
    Wang L; Sharma A
    ChemMedChem; 2020 Nov; 15(22):2072-2097. PubMed ID: 32916035
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Definition of functionally important mechanistic differences among selective estrogen receptor down-regulators.
    Wittmann BM; Sherk A; McDonnell DP
    Cancer Res; 2007 Oct; 67(19):9549-60. PubMed ID: 17909066
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of SUMOylation in full antiestrogenicity.
    Hilmi K; Hussein N; Mendoza-Sanchez R; El-Ezzy M; Ismail H; Durette C; Bail M; Rozendaal MJ; Bouvier M; Thibault P; Gleason JL; Mader S
    Mol Cell Biol; 2012 Oct; 32(19):3823-37. PubMed ID: 22826433
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antagonists for Constitutively Active Mutant Estrogen Receptors: Insights into the Roles of Antiestrogen-Core and Side-Chain.
    Sharma A; Toy W; Guillen VS; Sharma N; Min J; Carlson KE; Mayne CG; Lin S; Sabio M; Greene G; Katzenellenbogen BS; Chandarlapaty S; Katzenellenbogen JA
    ACS Chem Biol; 2018 Dec; 13(12):3374-3384. PubMed ID: 30404440
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficient synthesis of a multi-substituted diphenylmethane skeleton as a steroid mimetic.
    Misawa T; Tanaka K; Demizu Y; Kurihara M
    Bioorg Med Chem Lett; 2017 Jun; 27(11):2590-2593. PubMed ID: 28400239
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Screening Assay Cascade to Identify and Characterize Novel Selective Estrogen Receptor Downregulators (SERDs).
    Callis R; Rabow A; Tonge M; Bradbury R; Challinor M; Roberts K; Jones K; Walker G
    J Biomol Screen; 2015 Jul; 20(6):748-59. PubMed ID: 25851036
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of bivalent triarylalkene- and cyclofenil-derived dual estrogen receptor antagonists and downregulators.
    Knox A; Kalchschmid C; Schuster D; Gaggia F; Manzl C; Baecker D; Gust R
    Eur J Med Chem; 2020 Apr; 192():112191. PubMed ID: 32169784
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of the pharmacophore properties of novel selective estrogen receptor downregulators (SERDs).
    Kieser KJ; Kim DW; Carlson KE; Katzenellenbogen BS; Katzenellenbogen JA
    J Med Chem; 2010 Apr; 53(8):3320-9. PubMed ID: 20334372
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Symmetric 4,4'-(piperidin-4-ylidenemethylene)bisphenol derivatives as novel tunable estrogen receptor (ER) modulators.
    Sato M; Ohta K; Kaise A; Aoto S; Endo Y
    Bioorg Med Chem; 2016 Mar; 24(5):1089-94. PubMed ID: 26822566
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exploring the PROTAC degron candidates: OBHSA with different side chains as novel selective estrogen receptor degraders (SERDs).
    Li Y; Zhang S; Zhang J; Hu Z; Xiao Y; Huang J; Dong C; Huang S; Zhou HB
    Eur J Med Chem; 2019 Jun; 172():48-61. PubMed ID: 30939353
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Estrogenic activity of bis(4-hydroxyphenyl)methanes with cyclic hydrophobic structure.
    Kojima T; Ogawa T; Kitao S; Sato M; Oda A; Ohta K; Endo Y
    Bioorg Med Chem; 2015 Nov; 23(21):6900-11. PubMed ID: 26462053
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SCR-6852, an oral and highly brain-penetrating estrogen receptor degrader (SERD), effectively shrinks tumors both in intracranial and subcutaneous ER + breast cancer models.
    Zhou F; Yang G; Xue L; Liu Y; Guo Y; Zhu J; Yuan L; Gu P; Tang F; Shan J; Tang R
    Breast Cancer Res; 2023 Aug; 25(1):96. PubMed ID: 37580832
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dynamics-Based Discovery of Novel, Potent Benzoic Acid Derivatives as Orally Bioavailable Selective Estrogen Receptor Degraders for ERα+ Breast Cancer.
    Zhang X; Wang Y; Li X; Wu J; Zhao L; Li W; Liu J
    J Med Chem; 2021 Jun; 64(11):7575-7595. PubMed ID: 34056898
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis and evaluation of raloxifene derivatives as a selective estrogen receptor down-regulator.
    Shoda T; Kato M; Fujisato T; Misawa T; Demizu Y; Inoue H; Naito M; Kurihara M
    Bioorg Med Chem; 2016 Jul; 24(13):2914-2919. PubMed ID: 27185013
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.